The U.S. Food and Drug Administration issued a historic action making the first Gene Therapy available in the United States, ushering in a new approach to the treatment of cancer and other serious and life-threatening diseases. The FDA approved Kymriah (tisagenlecleucel) for certain pediatric and young adult patients with a form of acute lymphoblastic leukemia […]
This post first appeared on AuroBlog - The Official Blog Of Aurous HealthCare CRO, please read the originial post: here